 | Up a level |
Journal Article
Novello, S., Mazieres, J., Oh, I-J., de Castro, J., Migliorino, M. R., Helland, A., Dziadziuszko, R., Griesinger, F., Kotb, A., Zeiter, A., Cardona, A., Balas, B., Johannsdottir, H., Das-Gupta, A. and Wolf, J. (2017). Primary results from the phase III ALUR study of alectinib versus chemotherapy in previously treated ALK plus non-small-cell lung cancer (NSCLC). Ann. Oncol., 28. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
de Castro, J., Novello, S., Mazieres, J., Oh, I-J., Migliorino, M. R., Helland, A., Dziadziuszko, R., Griesinger, F., de Marinis, F., Zeaiter, A., Cardona, A., Balas, B., Johannsdottir, H., Chlistalla, M., Smoljanovic, V. and Wolf, J. (2017). CNS efficacy results from the phase III ALUR study of alectinib vs chemotherapy in previously treated ALK plus NSCLC. Ann. Oncol., 28. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041